How effective is Adderall Xr 25 for Narcolepsy? (a real world drug study)
Summary:
Overall ratings: 3.7/5 Long term ratings: 3.7/5
This is a phase IV clinical study of how effective Adderall xr 25 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is for Narcolepsy and for what kind of people. The study is created by eHealthMe from 3 Adderall xr 25 users and is updated continuously.
What is Adderall xr 25?
Adderall xr 25 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 345 Adderall xr 25 users. Check the latest studies of Adderall xr 25.
What is Narcolepsy?
Narcolepsy (brain's inability to regulate sleep-wake cycles normally) is found to be associated with 425 drugs and 738 conditions by eHealthMe. Check the latest studies of Narcolepsy.
3 people are studied for taking Adderall xr 25 in Narcolepsy
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Adderall xr 25 effectiveness for Narcolepsy (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 2
- very high: 0
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 2
- very high: 0
Gender of people who take Adderall xr 25 for Narcolepsy *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Adderall xr 25 for Narcolepsy *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 33.33 %
- 30-39: 0.0 %
- 40-49: 66.67 %
- 50-59: 0.0 %
- 60+: 0.0 %
Who find Adderall Xr 25 more effective for Narcolepsy?
Gender of people who take Adderall xr 25 for Narcolepsy *:
- female: 50 %
- male: 50 %
Age of people who take Adderall xr 25 for Narcolepsy *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 50 %
- 30-39: 0.0 %
- 40-49: 50 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Adderall xr 25?
- You can start a phase IV clinical trial to monitor Adderall xr 25 safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
- Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Adderall xr 25 (345 reports)
Treatments, associated drugs and conditions:
- Narcolepsy (79,888 reports)
How the study uses the data?
The study is based on amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate (the active ingredients of Adderall xr 25) and Adderall xr 25 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clopidogrel and Haloperidol drug interactions for women aged 60+ - now
- Could Cymbalta cause Enanthema? - 10 seconds ago
- Skelaxin and Cymbalta drug interactions for men aged 40-49 - 18 seconds ago
- Relapsing-Remitting Multiple Sclerosis and Autoimmune Disorder - 34 seconds ago
- Could Opdivo cause Skin Discoloration - Bluish? - 43 seconds ago
- Could Leflunomide cause Pulmonary Sarcoidosis? - 44 seconds ago
- Could Methotrexate cause Monocytosis? - 56 seconds ago
- Diarrhea Aggravated and drugs of ingredients of trospium chloride - a minute ago
- Sleep Disorder and drugs of ingredients of naloxone hydrochloride - a minute ago
- Injury and drugs of ingredients of meprobamate - a minute ago